Scroll back to top

MNG Laboratories Leadership

Syed Hussain

Syed Hussain Askree, MBBS, PhD, FACMG

Laboratory Director, MNG Laboratories, Atlanta, GA

Dr. Hussain Askree graduated from medical school in his native Pakistan in 1999 and received his doctorate in Genetics from University of Georgia in 2005. He pursued postdoctoral research in DNA damage from micronutrient deficiencies at the Center for Nutrition and Metabolism at Children’s Hospital Oakland Research Institute.

Dr. Askree completed two consecutive diagnostic genetics training fellowships at Emory University in Atlanta, GA and at the Mayo Clinic in Rochester, MN. He is dual-boarded in Clinical Molecular Genetics (2011) and Clinical Biochemical Genetics (2015) by the American Board of Medical Genetics and Genomics (ABMGG). His interests include molecular genetics of metabolic diseases, newborn screen follow-up testing and epigenetic mutation detection.

With 8 years of experience in operations and reporting in academic and commercial diagnostic laboratories, Dr. Askree serves as the Laboratory Director at MNG Laboratories. He also is an adjunct assistant professor in the department of Human Genetics at Emory University. He is certified by the New York State Department of Health as a Laboratory Director in the area of Genetic Testing.

Keith Hyland, PhD

Keith Hyland, PhD

Executive Vice President, MNG Laboratories, Atlanta, GA

Dr. Hyland received his doctorate in biochemistry from Brunel University, United Kingdom in 1980. His fellowships included Gustave Roussy Institute, Department of Biochemistry and Enzymology in Paris and the Department of Child Health, Institute of Child Health at the University of London.

In 1989 Dr. Hyland moved from the Institute of Child Health in London, where he had advanced to a lecturer in Biochemistry, to the Baylor Research Institute in Dallas, Texas where he held the positions of Senior Research Scientist at the Baylor Research Institute, Adjunct professor of Neurology at the University of Texas, Southwestern Medical Center and Professor of Biomedical Sciences at Baylor University.

In 2004, he moved to Atlanta to join Horizon Molecular Medicine, which became Medical Neurogenetics LLC in 2008.

In a career spanning 35 years, he has led numerous grant funded research teams in the UK and the US in the study of inherited disease and the neuroprotective molecular medicines used to treat them. He is a leading expert in the area of inherited disorders affecting serotonin, catecholamine, folate, and pyridoxal phosphate metabolism.

Dr. Hyland has been honored for his work in the area of Neurometabolic Disease, including the Noel Raine Award from the Society for the Study of Inborn Errors of Metabolism (1989 and 1998).

Trey Langley, PhD

Trey Langley, PhD

Vice President of Product Development and Reporting, MNG Laboratories, Atlanta, GA

Dr. Langley attained two bachelor degrees from the University of North Carolina at Chapel Hill in Biology and Clinical Laboratory Science. He subsequently worked as a Medical Technologist in the Core Lab of McLendon Clinical Laboratories at the University of North Carolina Hospitals, gaining experience in clinical laboratory operations. Dr. Langley went on to attain a PhD in Microbiology and Molecular Genetics from Emory University.

Dr. Langley has published on topics ranging from human genetics and immunology, to the development of novel anthrax and influenza vaccines.

Dr. Langley is certified by the New York State Department of Health as a Laboratory Director in the area of Genetic Testing (Molecular).

 Dr. Joseph M. Volpe

Joseph M. Volpe, PhD

Discipline Director, Clinical Neuroscience, LabCorp

Dr. Volpe graduated from Duke University in 2008 with PhD in computational biology and bioinformatics, with a concentration in immunology. His research involved developing a software algorithm to decipher the germline origins of human immunoglobulin and T-cell receptors and then using that software to analyze large data sets of human antibodies to understand their diversity. He received the American Association of Immunologists-Huang Foundation Young Investigator Award in 2007 for his work in anti-HIV antibody composition. Upon graduating, Dr. Volpe worked as a Medical Science Liaison at Monogram Biosciences where he covered the Southeast and Midwest territories. In early 2016, he became the Director of Scientific Outreach, helping to build the Medical Science Liaison team for Labcorp.

In early 2018, Dr. Volpe began putting together the pieces of what would become Labcorp’s Partners in Clinical Neuroscience program and he is now the National Segment Director for that program. He is an author on seven peer-reviewed articles and eight conference posters. In 2011, he was a Labcorp Chairman’s Award winner and was also the Monogram Biosciences MVP awardee.


Arunkanth Ankala

Clinical Laboratory Director

Dr. Ankala is a board certified Clinical Molecular Geneticist. He has a bachelor and a master degree in Biochemistry from India. He received his doctorate in Molecular Biology from Mississippi State University in 2010. He then pursued postdoctoral research in Neuromuscular Disorders at Emory University School of Medicine.

Dr. Ankala trained in Clinical Molecular Genetics at Emory University and is currently certified by the American Board of Medical Genetics and Genomics (ABMGG). His primary research focus and interests have been clinical applications of next generation sequencing methodologies and molecular diagnosis of neuromuscular disorders.

Dr. Ankala has over 8 years of combined training and experience in the field of Clinical Molecular Genomics. Prior to joining MNG Laboratories, Dr. Ankala held the position of Assistant Professor in Human Genetics at Emory University where he also served as the Program Director for the Laboratory Fellowship Program. He continues to be an Adjunct Assistant Professor in Human Genetics at Emory University. He is certified by the New York State Department of Health and the Georgia Department of Community Health as a Clinical Laboratory Director.